WHY DO STUDY SUBJECTS PARTICIPATE IN CLINICAL TRIALS?
1) To assist in bringing improved medications and treatments to the general public.
2) To get access to new treatments unavailable to the general public.
3) No insurance is needed, study related assessments and medicine are provided at
no cost, and stipend compensation is typically issued to the patient for their
participation.
Join A Study
Do you want to participate in or learn more about our clinical trials? Call to see if you
may qualify for one of our ongoing trials.
Call: 770-777-1928
PHASES OF CLINICAL TRIALS:
A Phase I Study:
The initial phase of testing involves a small number of healthy volunteers, who are
usually paid for participating in the study.
The study is designed to determine how the drug is absorbed and metabolized in the
human body. A phase I study will also observe side effects that occurs as dosage
levels are increased.
A Phase II Study:
The second phase tests the medicine's efficacy and usually involves up to several
hundred patients. It is used for the first time in the target population.
In Phase II studies the subject is typically randomized to either an investigational
medicine or a similar treatment or placebo. Often neither the patients nor the
researchers know who is getting the experimental drug and who is not. These are
called "blinded" studies.
A Phase III Study:
In a phase III study, a drug is tested in a much larger patient population. Phase III
trials are utilized by the pharmaceutical sponsor for FDA submission. Based on
Phase III data the FDA can grant approval to market the medication to the general
public.
A Phase IV Studies:
In phase IV studies marketed medications are compared against one another for the
purpose of trying to show the superiority of one over another.
1) To assist in bringing improved medications and treatments to the general public.
2) To get access to new treatments unavailable to the general public.
3) No insurance is needed, study related assessments and medicine are provided at
no cost, and stipend compensation is typically issued to the patient for their
participation.
Join A Study
Do you want to participate in or learn more about our clinical trials? Call to see if you
may qualify for one of our ongoing trials.
Call: 770-777-1928
PHASES OF CLINICAL TRIALS:
A Phase I Study:
The initial phase of testing involves a small number of healthy volunteers, who are
usually paid for participating in the study.
The study is designed to determine how the drug is absorbed and metabolized in the
human body. A phase I study will also observe side effects that occurs as dosage
levels are increased.
A Phase II Study:
The second phase tests the medicine's efficacy and usually involves up to several
hundred patients. It is used for the first time in the target population.
In Phase II studies the subject is typically randomized to either an investigational
medicine or a similar treatment or placebo. Often neither the patients nor the
researchers know who is getting the experimental drug and who is not. These are
called "blinded" studies.
A Phase III Study:
In a phase III study, a drug is tested in a much larger patient population. Phase III
trials are utilized by the pharmaceutical sponsor for FDA submission. Based on
Phase III data the FDA can grant approval to market the medication to the general
public.
A Phase IV Studies:
In phase IV studies marketed medications are compared against one another for the
purpose of trying to show the superiority of one over another.
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |